Locations
Dublin, Ireland · Leinster, Ireland
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2015
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens. The company is focused on creating new effective oral treatments, specifically sulopenem, which is the first oral and IV penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative infections in both hospital and community settings. Iterum's unique solutions address the urgent medical need for new options in the fight against antibiotic-resistant infections, positioning the company as a key player in the pharmaceutical industry.
Something looks off?